Who Gains, Who Loses on Syam Adusumilli

The MA Plan Landscape Under Pressure

Sun, 15 Mar 2026 00:00:00 +0000

The Medicare Advantage industry entered the 2024–2026 rate cycle in a posture it had not occupied in a decade: retreating. Benefit contraction, county exits, prior authorization tightening, and earnings revisions replaced the supplemental benefit expansion and membership growth that defined the prior decade. The rate compression began with the CY2024 advance notice, which produced an effective rate reduction once coding intensity adjustments, V28 model phase-in, and benchmark changes were combined. What the plans had absorbed individually in prior cycles arrived simultaneously, and the plans that had built growth strategies around supplemental benefit expansion faced the sharpest structural correction.

Summary: The MA Plan Landscape Under Pressure

Sun, 15 Mar 2026 00:00:00 +0000

The Medicare Advantage industry entered the 2024-2026 rate cycle in retreat. Benefit contraction, county exits, prior authorization tightening, and earnings revisions replaced the supplemental benefit expansion and membership growth that defined the prior decade. The rate compression that began with the CY2024 advance notice arrived simultaneously across coding intensity adjustments, V28 model phase-in, and benchmark changes, and the plans that had built growth strategies around supplemental benefit expansion faced the sharpest structural correction.

Health System Winners and Losers

Sun, 15 Mar 2026 00:00:00 +0000

The payvider thesis holds that health systems with insurance operations are structurally advantaged in a value-based payment environment. The logic is straightforward: a system that controls both the clinical delivery and the insurance risk has aligned incentives, generates encounter data at point of care, and can manage total cost through clinical design rather than administrative denial. That logic has been tested against real market conditions over the past five years, and the results are not uniform. Some systems have seen the thesis validated. Others have demonstrated its failure modes. This article examines five named organizations through the policy changes that are reshaping provider strategy: AHEAD global budgets, encounter-based risk adjustment, D-SNP integration, and ACO performance accountability.

Summary: Health System Winners and Losers

Sun, 15 Mar 2026 00:00:00 +0000

The payvider thesis holds that health systems with insurance operations are structurally advantaged in a value-based payment environment because a system controlling both clinical delivery and insurance risk has aligned incentives, generates encounter data at point of care, and manages total cost through clinical design rather than administrative denial. That logic has been tested against real market conditions over the past five years, and the results are not uniform. Some systems have seen the thesis validated. Others have exposed its failure modes. Five named organizations illustrate different trajectories under the policy changes reshaping provider strategy: AHEAD global budgets, encounter-based risk adjustment, D-SNP integration, and ACO performance accountability.

The ACO Accountability Ratchet

Sun, 15 Mar 2026 00:00:00 +0000

CMS has 53 million Traditional Medicare beneficiaries. Approximately 53 percent of them are attributed to an ACO through MSSP or ACO REACH. The 511 MSSP ACOs generated $5.7 billion in gross savings in 2023, with $2.7 billion returned to Medicare after shared savings payments. ACO REACH generated additional savings. The aggregate numbers are good. The distribution is not uniform.

The organizations generating the most savings are measurably different from those generating none, and the performance gap is widening. ACOs that accepted two-sided risk outperform those that did not. Physician-led ACOs outperform hospital-led ACOs. ACOs with high voluntary attribution outperform those dependent on claims-based assignment. The pattern is consistent enough across years that it is structural rather than incidental. This article maps who is generating savings, what distinguishes them, and what the accountability pressure building into the model design means for the organizations that have been participating without generating results.

Summary: The ACO Accountability Ratchet

Sun, 15 Mar 2026 00:00:00 +0000

CMS has 53 million Traditional Medicare beneficiaries. Approximately 53 percent are attributed to an ACO through MSSP or ACO REACH. The 511 MSSP ACOs generated $5.7 billion in gross savings in 2023, with $2.7 billion returned to Medicare after shared savings payments. The aggregate numbers are strong. The distribution is not uniform, and the performance gap between the organizations generating savings and those generating none is widening in ways that are structural rather than incidental.

The HealthTech Company Ecosystem

Sun, 15 Mar 2026 00:00:00 +0000

The HealthTech sector targeting the Medicare population includes a range of companies making claims about their Medicare revenue potential that range from well-grounded to speculative to materially misleading. Some of this misrepresentation is intentional. Much of it reflects a genuine misunderstanding of what CMS pays for, what CMMI models enable, and how long it takes for a policy opening to become a sustainable revenue stream.

The confusion between a policy opening and a reimbursement pathway is the central analytical problem. A CMMI model creates a payment mechanism that operates during the model’s test period, for participants enrolled in the model, in markets where the model runs. It does not create a Medicare benefit. It does not establish a billing code. It does not guarantee that a company providing services within the model will generate sustainable revenue when the model ends or expands to standard Medicare. Companies that describe their CMMI participation as Medicare coverage, or their total addressable market as the Medicare-eligible population without specifying their actual reimbursement pathway, are making claims that investor materials and public company filings occasionally do not support.

Summary: The HealthTech Company Ecosystem

Sun, 15 Mar 2026 00:00:00 +0000

The HealthTech sector targeting the Medicare population includes companies making claims about Medicare revenue potential that range from well-grounded to materially misleading. The confusion between a policy opening and a reimbursement pathway is the central analytical problem. A CMMI model creates a payment mechanism operating during the model’s test period, for enrolled participants, in markets where the model runs. It does not create a Medicare benefit, establish a billing code, or guarantee that a company providing services within the model will generate sustainable revenue when the model ends. Companies describing CMMI participation as Medicare coverage, or framing total addressable market as the Medicare-eligible population without specifying their actual reimbursement pathway, are making claims that public filings do not always support.

Home Care and PACE Organizations

Sun, 15 Mar 2026 00:00:00 +0000

The home is becoming the default site of care. The policy signals are consistent across every major reform track: AHEAD incentivizes hospitalization avoidance, FIDE SNP requirements mandate LTSS coordination, HHVBP links home health payment to quality outcomes, and OBBBA’s rural health provisions include PACE expansion funding. Every major payment model reform running simultaneously is pointing at the same organizational infrastructure: home health agencies, non-medical home care organizations, and PACE programs.

Summary: Home Care and PACE Organizations

Sun, 15 Mar 2026 00:00:00 +0000

The home is becoming the default site of care across every major Medicare reform track. AHEAD incentivizes hospitalization avoidance. FIDE SNP requirements mandate LTSS coordination. HHVBP links home health payment to quality outcomes. OBBBA’s rural health provisions include PACE expansion funding. Every major payment model running simultaneously points at the same organizational infrastructure: home health agencies, non-medical home care organizations, and PACE programs. The organizations that have built the capacity to deliver clinical care in the home are at the center of a policy convergence that could expand their role materially or expose the structural fragility beneath it. That fragility is workforce. The home care workforce crisis is not contextual background. It is the binding constraint on every model’s execution, and no amount of payment model redesign resolves a labor market problem that payment model redesign did not create.